Target intelligence / Profile preview

Lysosomal and endosomal compartments in antigen-presenting cells

Molecular classification
Other
01

Overview

The lysosomal and endosomal compartments in antigen-presenting cells (APCs) constitute a critical subcellular system responsible for the internalization, processing, and presentation of exogenous antigens (Roche & Furuta, 2015, Nature Reviews Immunology). These compartments, which include early endosomes, late endosomes, and lysosomes, provide the acidic environment and proteolytic enzymes (such as cathepsins) necessary to degrade proteins into peptides (Watts, 2012, Annual Review of Immunology). These peptides are then loaded onto MHC class II molecules for presentation to T cells, a process essential for initiating adaptive immune responses. Additionally, these compartments house various pattern recognition receptors, such as Toll-like receptors 7 and 9, which sense nucleic acids (Kuznik et al., 2011, Journal of Immunology). Pharmacological modulation of these compartments, typically through the use of lysosomotropic agents like hydroxychloroquine, aims to increase the internal pH, thereby inhibiting antigen processing and downstream inflammatory signaling in autoimmune conditions like systemic lupus erythematosus and rheumatoid arthritis (Schrezenmeier & Dörner, 2020, Nature Reviews Rheumatology). This system is also a target for pathogens that exploit endocytic pathways for cellular entry.

Other names
Endo-lysosomal systemEndocytic pathwayMHC class II compartmentMIIC
02

Mechanism of action

Inhibition of endosomal acidification and lysosomal enzyme activity, leading to impaired antigen processing and presentation, as well as reduced Toll-like receptor (TLR) signaling.

03

Biological functions

Antigen processingAntigen presentationEndocytosisProtein degradationToll-like receptor signaling
04

Disease associations

Autoimmune diseaseInfectionInflammation
05

Safety considerations

RetinopathyCardiotoxicityNeuromyopathy
06

Interacting drugs

Hydroxychloroquine

1 more in the full profile.

07

Biomarkers

Lysosomal pHMHC class II surface expression

Beyond the preview

Go deeper on Lysosomal and endosomal compartments in antigen-presenting cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysosomal and endosomal compartments in antigen-presenting cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call